CIERRA WILLIAMS: Open Payments
NPI 1730557752 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 24 payments from 11 companies in 2025. Trend: 2023 $166 · 2024 $267 · 2025 $587
Food & beverage: $582Education: $6
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $209 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 2 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Calliditas Therapeutics US Inc. | 2 | $56 |
| Ardelyx, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Aurinia Pharma U.S., Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: KRYSTEXXA, Fabhalta, JYNARQUE, Kerendia, TARPEYO, IBSRELA, JARDIANCE, LUPKYNIS.
Industry payments across GA — which companies pay providers there.
